Hot Investor Mandate 3: China Fund Seeks Innovative Antibiotics

3 Mar

A Life Science focused investment fund based in Shanghai, China was founded by successful Chinese and American entrepreneurs in the healthcare industry. The fund primarily considers investments based in China or has a significant China nexus. For example, the company must have a principal market in China, or R&D/manufacturing/sales in China. The fund prefers to follow and take minority stake. Investment size varies but typically ranges from US$1-4 million. The fund prefers business models that are marketing/sales oriented (vs. technology oriented). The fund is actively seeking new investment opportunities.

Currently the fund is looking for innovative antibiotics or alternatives to antibiotics in human health, animal health, and agriculture. For the stage of development, the fund seeks products that are able to enter the market within 2 years post investment. Historically, the fund invested in a medical supplier, medical devices, and AgBio.

The fund seeks an experienced management team that has “done it before.” The fund will consider US-based companies as long as the China nexus criteria is met. The firm seeks to make minority investment and typically requires China rights.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: